Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03795740
Other study ID # liusheng-1999
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2017
Est. completion date December 31, 2022

Study information

Verified date December 2018
Source Chinese Academy of Medical Sciences, Fuwai Hospital
Contact Sheng Liu, MD
Phone 13501331366
Email liusheng@fuwai.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a effectiveness study of the application of high-definition enhanced computed-tomography for patients with chronic thromboembolic pulmonary hypertension(CTEPH).The patients with CTEPH was randomized into 2 groups,precise pulmonary endarterectomy group(guided by enhanced CT scanning) and traditional pulmonary endarterectomy group,the hemodynamic changes tested with right sided heart catherization from baseline to post-operative period and end-point including peri-operative deaths,follow-up mortality,follow-up parameters of ultrasonic cardiogram(UCG),right-sided heart catherization(RHC),nuclear magnetic resonance imaging(MRI),cardiac pulmonary exercise test(CPET) are documented,so as to compare the prognosis between these 2 groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 72
Est. completion date December 31, 2022
Est. primary completion date May 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 85 Years
Eligibility Inclusion Criteria:

- Definite diagnosed with chronic thromboembolic pulmonary hypertension with the right-sided cathrization and pulmonary angiography;

- The computed tomography imaging implied that the location of the embolism could be reached with surgeries;

Exclusion Criteria:

- Beyond the age limit described above,or combined with other severe conditions such as severe organ dysfunction and considered contraindicated for surgical therapy by the cardiac surgeons;

- Without the consent by the patient or his/her families;

- Acute pulmonary embolism;

- Pulmonary sarcoma;

- Pulmonary arteritis;

- Combined with cardiogenic pulmonary hypertension or idiopathic pulmonary hypertension;

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
3-D CT scanning
For patients in Group 1,precisely analyzed CT scanning and/or pulmonary angiography will be done,and the patients in Group 1 will receive PEA procedure with the guide of precise 3-D imaging techniques

Locations

Country Name City State
China Fuwai Hospital,Chinese Academy of Medical Sciences Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Sheng Liu

Country where clinical trial is conducted

China, 

References & Publications (7)

Coquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, Stricker H, Pagnamenta A, Ott S, Ulrich S, Györik S, Pasquier J, Aubert JD. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J. 2018 Apr 4;51(4). pii: 1702505. doi: 10.1183/13993003.02505-2017. Print 2018 Apr. — View Citation

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29. — View Citation

Inami T, Kataoka M, Ando M, Fukuda K, Yoshino H, Satoh T. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014 Apr 11;9(4):e94587. doi: 10.1371/journal.pone.0094587. eCollection 2014. — View Citation

Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4. — View Citation

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States. Curr Med Res Opin. 2011 Sep;27(9):1763-8. doi: 10.1185/03007995.2011.604310. Epub 2011 Jul 27. — View Citation

Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 May 27;350(22):2257-64. — View Citation

Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline pulmonary systolic pressure within 1 month Systolic pulmonary pressure result tested by right-sided heart within 1 month before and after pulmonary endarterectomy surgery
Primary Change from Baseline pulmonary mean pressure within 1 month Mean pulmonary pressure result tested by right-sided heart within 1 month before and after pulmonary endarterectomy surgery
Primary Change from Baseline pulmonary vascular resistance within 1 month Pulmonary vascular resistance result tested by right-sided heart within 1 month before and after pulmonary endarterectomy surgery
Primary Change from Baseline cardiac output within 1 month Cardiac output result tested by right-sided heart within 1 month before and after pulmonary endarterectomy surgery
Primary mortality rate after surgery mortality rate after surgery immediately after the surgery to the longest 48 months follow-up period
Secondary Follow-up right ventricular ejection fraction Assessed by UCG 3-24 months after the surgeries
Secondary Follow-up tricuspid annular plane systolic excursion Assessed by UCG 3-24 months after the surgeries
Secondary Follow-up right ventricular anterior-posterior diameter Assessed by UCG 3-24 months after the surgeries
Secondary Follow-up tricuspid insufficiency level Assessed by UCG 3-24 months after the surgeries
Secondary Follow-up peak oxygen consumption (Peak O2) result Assessed by cardio-pulmonary exercise test (CPET) 6-24 months after the surgeries
Secondary Follow-up Peak O2% Assessed by CPET 6-24 months after the surgeries
Secondary Follow-up 6-minutes walking distance Assessed by CPET 6-24 months after the surgeries
Secondary follow-up NYHA classes NYHA classes in the follow up period,either with telephone follow-up or out-patient follow up 6-24 months after surgeries
See also
  Status Clinical Trial Phase
Recruiting NCT05050617 - Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Completed NCT03915925 - Short-term Clinical Deterioration After Acute Pulmonary Embolism
Completed NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT04454554 - Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
Completed NCT03173066 - Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography Phase 1
Terminated NCT03002467 - Impact Analysis of Prognostic Stratification for Pulmonary Embolism N/A
Completed NCT02611115 - Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. N/A
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT01975090 - The SENTRY Clinical Study N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT01326507 - Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism N/A
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT00780767 - Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism Phase 2
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2